Clare Lloyd

Title: Clare Lloyd: Innovator in GPCR-like Molecules

Introduction

Clare Lloyd is a notable inventor based in London, GB. He has made significant contributions to the field of molecular biology, particularly in the area of G protein-coupled receptors (GPCRs). His innovative work has led to the development of novel polypeptides and proteins that have potential applications in diagnostics and therapeutics.

Latest Patents

Clare Lloyd holds a patent for "Nucleic acid encoding 15571, a GPCR-like molecule of the secretin-like family." This patent discloses various GPCR-like polypeptides, proteins, and nucleic acid molecules. The invention includes isolated, full-length GPCR-like proteins, fusion proteins, antigenic peptides, and anti-GPCR-like antibodies. Additionally, it provides GPCR-like nucleic acid molecules, recombinant expression vectors, host cells, and nonhuman transgenic animals with introduced or disrupted GPCR-like genes. The patent also outlines diagnostic, screening, and therapeutic methods utilizing the compositions of the invention.

Career Highlights

Clare Lloyd has been associated with Millennium Pharmaceuticals Limited, where he has furthered his research and development efforts. His work has been instrumental in advancing the understanding of GPCR-like molecules and their potential applications in medicine.

Collaborations

Clare has collaborated with notable colleagues, including Martin R Hodge and Nadine Weich, who have contributed to his research endeavors.

Conclusion

Clare Lloyd's innovative work in the field of GPCR-like molecules showcases his dedication to advancing molecular biology. His patent reflects significant advancements that could lead to new therapeutic methods and diagnostic tools.